Cancer
Conditions
Brief summary
The purpose of this study is to learn about the experiences of cancer patients during treatment utilizing a mobile app called EveryDose© to track prescribed oral treatment for cancer. Based on these experiences, the study team will decide on expanding this pilot study to evaluate other methods that may prove to be beneficial in supporting cancer patient's ability to take cancer medications as prescribed (another common phrase used for this is adherence to treatment).
Interventions
BEHAVIORALEveryDose Mobile Application
Participants will use this application every day for up to 10 minutes, for up to 12 weeks. The purpose of the application is to improve medication adherence. Participants will receive an alert to the mobile device while at home to ensure medication was taken, and to serve as a medication log.
Sponsors
University of Miami
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Any sex/gender Able to provide written informed consent * Able to read/understand English or Spanish * Diagnosis of hematologic or solid tumor cancer diagnosis * Prescribed an oral anti-cancer drug as monotherapy treatment for the first time by their treating oncologist. * Internet access on a smartphone, tablet, or computer
Exclusion criteria
* Less than 18 years of age * Unable to provide written informed consent * Unable to read/understand English or Spanish * History of dementia or major psychiatric disease that would interfere with study participation * Prior treatment with an oral anti-cancer treatment * Participating in another clinical trial during the time of screening.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of patients who agree to use the EveryDose application | up to 12 weeks | Percentage of patients who agree to use the EveryDose application |
| EveryDose application adherence measured by percentage | up to 12 weeks | The percentage of weeks out of 12 week-period that the patient used the App (\> 50%) |
| Medication Adherence measured by dose ratio | up to 12 weeks | Will be measured by the ratio of doses taken to the doses prescribed over a given time period. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of patient satisfaction measured by SUS | 12 weeks (post intervention) | Percentage of patients who are satisfied with the EveryDose© mobile app (at least 80%) via the Systems Usability (SUS) survey by providers and patients. Survey asks patient about their satisfaction with the mobile application. Responses range from strongly disagree to strongly agree. |
Countries
United States
Contacts
CONTACTJessica MacIntyre, DNP
PRINCIPAL_INVESTIGATORFrank Penedo, PhD
University of Miami
Outcome results
None listed